Korean J Clin Pathol.  2000 Jun;20(3):308-313.

Investigation of Risk Factors for Vancomycin-Resistant Enterococci(VRE) Infection and Colonization

Affiliations
  • 1Department of Clinical Pathology, Ewha Womans University College of Medicine, Seoul, Korea.

Abstract

BACKGROUND: The emergence of vancomycin-resistant enterococci(VRE) is increasingly serious problem throughout the world and is likely to increase in Korea. However, a few epidemiologic studies and risk factors of VRE infection have been reported in Korea. We investigated risk factors for VRE infection and colonization.
METHODS
We analyzed 48 patients with VRE(24 infection, 24 fecal colonization) and 62 vancomycin-sensitive enterococci(VSE) in Ewha Womans university hospital from January 1997 to December 1998 and we performed case-control study to assess the risk factors for VRE.
RESULTS
The incidence of VRE infection was 7.3% of all enterococcal isolates and the incidence of VRE colonization from surveillance cultures was increased 0.1% to 1.5% from 1997 to 1998. Compared with patients with VSE, patients with VRE had significantly longer hospital stays. They also had more frequent stays in intensive care unit(ICU) and oncology wards. They had more frequent invasive procedures such as central lines, urinary catheters, nasogastric tubes, ventilators and were more likely to have received vancomycin or teicoplanin or aztreonam or aminoglycosides or cephalosporins therapy(P<0.05). Compared with the patients infected with VRE, the patients colonized with VRE had significantly more frequent stays in the ICU(P <0.05).
CONCLUSIONS
To prevent the VRE infection and colonization, appropriate antibiotic therapy according to the guidelines and cautious handling of medical devices may be necessary.

Keyword

Vancomycin-resistant enterococci(VRE); VRE infection; Fecal colonization; Risk factor

MeSH Terms

Aminoglycosides
Aztreonam
Case-Control Studies
Cephalosporins
Colon*
Epidemiologic Studies
Female
Humans
Incidence
Critical Care
Korea
Length of Stay
Risk Factors*
Teicoplanin
Urinary Catheters
Vancomycin
Ventilators, Mechanical
Aminoglycosides
Aztreonam
Cephalosporins
Teicoplanin
Vancomycin
Full Text Links
  • KJCP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr